Brainard Diana

CIK 00018180702 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001818070

Recent Transactions

50 trades

Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2025-09-30+8,000→ 8,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-19$0.55/sh−8,706→ 723,363 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-11-05$0.86/sh−10,609→ 732,069 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-21$0.78/sh−9,752→ 742,678 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-10-03$0.81/sh−1,493→ 752,430 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2024-09-18+120,000→ 120,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-20$0.74/sh−5,390→ 753,923 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-19$0.76/sh−3,091→ 759,313 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-08-05$0.73/sh−10,847→ 762,404 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-19$0.75/sh−9,731→ 773,251 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-07-02$0.72/sh−1,489→ 782,982 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-21$0.79/sh−5,149→ 784,471 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-17$0.75/sh−3,075→ 789,620 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-05-03$0.80/sh−10,240→ 792,695 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-19$0.75/sh−9,601→ 802,935 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-04-02$0.77/sh−1,533→ 812,536 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-21$0.71/sh−5,155→ 814,069 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-20$0.70/sh−3,097→ 819,224 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-02-05$0.67/sh−41,421→ 822,321 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-23$0.67/sh−9,500→ 863,742 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2024-01-04$0.64/sh−1,664→ 873,242 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-11-20$1.69/sh−4,382→ 874,906 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-11-17$1.63/sh−2,689→ 879,288 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-19$1.58/sh−8,581→ 881,977 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-10-03$1.98/sh−1,325→ 890,558 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2023-09-19+85,000→ 85,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-08-18$2.79/sh−4,055→ 891,883 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-08-17$2.50/sh−11,361→ 895,938 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-19$3.56/sh−8,342→ 907,299 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-07-05$3.05/sh−5,275→ 915,641 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-05-18$4.21/sh−4,536→ 916,628 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-04-19$3.71/sh−8,408→ 921,164 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-02-21$6.63/sh−5,122→ 929,572 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2023-02-02+617,500→ 1,836,875 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-02-02+332,500→ 934,964 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2023-01-19$5.08/sh−34,435→ 601,607 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-11-18$7.27/sh−4,515→ 633,033 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2022-09-16+20,400→ 20,400 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2022-09-16+10,200→ 28,560 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-18$7.76/sh−4,564→ 637,548 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-08-16+100,000→ 642,112 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+89,375→ 89,375 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+48,125→ 542,112 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-05-18$4.33/sh−29,135→ 492,165 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-01-18+585,000→ 585,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-18+315,000→ 521,300 total
Award
NEKTAR THERAPEUTICS$NKTR
Stock Option
2021-11-11+36,720→ 36,720 total
Award
NEKTAR THERAPEUTICS$NKTR
Common Stock
2021-11-11+18,360→ 18,360 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-05-17+30,000→ 36,300 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-05-17+170,000→ 206,300 total

Brainard Diana

Recent Transactions

Companies

Recent Filings

Address